Ondansetron should never be used in pregnancy: Against: Ondansetron in pregnancy revisited

BJOG. 2021 Jan;128(1):111-112. doi: 10.1111/1471-0528.16476. Epub 2020 Sep 29.

P Damkier^{1

2}, Y C Kaplan³, S Shechtman⁴, O Diav-Citrin^{4

5}, M Cassina⁶, C Weber-Schoendorfer^{7

8}, B Cleary^{9

10}, K Hodson¹¹

¹ Department of Clinical Biochemistry & Pharmacology, Odense University Hospital, Odense, Denmark.
² Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
³ Terafar - Izmir Katip Celebi University Teratology Information, Training and Research Centre, Izmir, Turkey.
⁴ The Israeli Teratology Information Service, Ministry of Health, Jerusalem, Israel.
⁵ The Hebrew University Hadassah Medical School, Jerusalem, Israel.
⁶ Clinical Genetics Unit, Department of Women's and Children's Health, University of Padua, Padua, Italy.
⁷ Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
⁸ Berlin Institute of Health, Pharmakovigilanzzentrum, Embryonaltoxikologie, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany.
⁹ School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
¹⁰ The Rotunda Hospital, Dublin, Ireland.
¹¹ The UK Teratology Information Service, Newcastle upon Tyne, UK.

No abstract available

MeSH terms